Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Low molecular weight iron"'
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 20, Iss 2, Pp 208-211 (2009)
This study aimed to assess the safety and efficacy of iron sucrose in hemodialysis (HD) patients with documented hypersensitivity reactions to iron dextran. Of 205 HD patients who received low molecular weight iron dextran, 15 (7.3%) patients develop
Externí odkaz:
https://doaj.org/article/6bb9b11607074d7fbb9d9f81dd95ea3c
Autor:
Xie, Jing, Haeckel, Akvile, Hauptmann, Ralf, Ray, Iweta Pryjomska, Limberg, Christian, Kulak, Nora, Hamm, Bernd, Schellenberger, Eyk
Purpose Low molecular weight iron(III) complex‐based contrast agents (IBCA) including iron(III) trans‐cyclohexane diamine tetraacetic acid [Fe(tCDTA)]− could serve as alternatives to gadolinium‐based contrast agents in MRI. In search for IBCA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______133::f932551ddac8a4793982da057bcffd6b
http://edoc.hu-berlin.de/18452/23145
http://edoc.hu-berlin.de/18452/23145
Autor:
Xie, Jing, Haeckel, Akvile, Hauptmann, Ralf, Ray, Iweta Pryjomska, Limberg, Christian, Kulak, Nora, Hamm, Bernd, Schellenberger, Eyk
Purpose: Low molecular weight iron(III) complex-based contrast agents (IBCA) including iron(III) trans-cyclohexane diamine tetraacetic acid [Fe(tCDTA)](-) could serve as alternatives to gadolinium-based contrast agents in MRI. In search for IBCA with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4cc19ce979ffecd8e4434aeb4312b6b
https://doi.org/10.17169/refubium-34018
https://doi.org/10.17169/refubium-34018
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sunil Bhandari
Publikováno v:
NDT Plus
The National Service Framework advocates correction of anaemia in patients with chronic kidney disease (CKD). Oral iron is insufficient, while intravenous (IV) supplementation replenishes and maintains iron stores. Previously, effective delivery of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bcf00f6ccf9f0032d7593cf25800da6
https://pubmed.ncbi.nlm.nih.gov/27045221
https://pubmed.ncbi.nlm.nih.gov/27045221
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 20, Iss 2, Pp 208-211 (2009)
This study aimed to assess the safety and efficacy of iron sucrose in hemodialysis (HD) patients with documented hypersensitivity reactions to iron dextran. Of 205 HD patients who received low molecular weight iron dextran, 15 (7.3%) patients develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dda1c22860e2e70113b413b971d412eb
http://www.sjkdt.org/article.asp?issn=1319-2442
http://www.sjkdt.org/article.asp?issn=1319-2442
Autor:
Julia A Critchley, Yenal Dundar
Publikováno v:
Transfusion Alternatives in Transfusion Medicine. 9:8-36
SUMMARY Intravenous iron administration is an effective method of treating iron deficiency anemia, but there have been concerns about adverse side effects, particularly serious events such as anaphylactic reaction. Several different forms of intraven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f22a7a92ce93718fdf57d2add3b936f
https://doi.org/10.1111/j.1778-428x.2007.00042.x
https://doi.org/10.1111/j.1778-428x.2007.00042.x
Autor:
Matteo Neri, Domenico Lapenna, Franco Cuccurullo, Sante Ucchino, Sante D. Pierdomenico, Giuliano Ciofani, Maria Adele Giamberardino
Publikováno v:
Free Radical Biology and Medicine. 42:492-498
The association between iron, an oxidant catalyst, and atherosclerosis is controversial. In particular, it is unknown whether: (1) stored iron, namely serum ferritin, is correlated with catalytic iron and oxidant damage of human atherosclerotic plaqu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0856c5f7504a3b5d600454c1b0eb5819
https://doi.org/10.1016/j.freeradbiomed.2006.11.014
https://doi.org/10.1016/j.freeradbiomed.2006.11.014